Stephan Eismann

Stephan Eismann leads ML development at Atomic AI, where his team builds new technology to discover RNA-targeting medicines. Before joining Atomic, he completed his PhD in the AI Laboratory at Stanford University, focusing on machine learning algorithms to address challenges in biomolecular structure prediction. Originally from Germany, he studied physics in Heidelberg and London before moving to the US. He is a co-founder of the Machine Learning for Structural Biology workshop at NeurIPS, and his research has been published in Science and Nature as well as at NeurIPS and ICML.